Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Kotak Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD.15.442240000067.1040
Domestic EquitiesMax Healthcare Institute Ltd.7.897530500034.3186
Domestic EquitiesDivis Laboratories Ltd.6.08634000026.4480
Domestic EquitiesCipla Ltd.5.059415000021.9855
Domestic EquitiesJUBILANT PHARMOVA LIMITED3.781714000016.4332
Domestic EquitiesJB Chemicals & Pharmaceuticals Ltd.3.66479500015.9249
Domestic EquitiesLupin Ltd.3.24377200014.0954
Domestic EquitiesApollo Hospitals Enterprise Ltd.3.16672000013.7610
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.06844200013.3337
Domestic EquitiesDr.Reddy's Laboratories Ltd.2.879310000012.5120
Domestic EquitiesAlkem Laboratories Ltd.2.81592400012.2364
Domestic EquitiesASTER DM HEALTHCARE LTD2.767221500012.0250
Domestic EquitiesAurobindo Pharma Ltd.2.667810100011.5928
Domestic EquitiesMarksans Pharma Ltd2.647044000011.5025
Domestic EquitiesZydus Lifesciences Ltd.2.461211500010.6950
Domestic EquitiesAmi Organics Ltd2.43639000010.5867
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL2.361915000010.2638
Domestic EquitiesAjanta Pharma Ltd.2.2752393779.8868
Domestic EquitiesMANKIND PHARMA LTD2.2715400009.8708
Domestic EquitiesSAI LIFE SCIENCES LIMITED2.17741250009.4619
Domestic EquitiesYATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD1.95611680678.5000
Domestic EquitiesFortis Healthcare India Ltd1.95041200008.4756
Domestic EquitiesGlenmark Pharmaceuticals Ltd1.9113570008.3055
Domestic EquitiesINNOVA CAPTABS LTD1.8598920008.0817
Domestic EquitiesLAXMI DENTAL LIMITED1.85462100108.0591
Domestic EquitiesHIKAL LTD1.79852100007.8152
Domestic EquitiesKrsnaa Diagnostics Ltd1.47311000006.4015
Domestic EquitiesGland Pharma Limited1.4623400006.3544
Domestic EquitiesORCHID PHARMA LIMITED1.44691000006.2875
Total 94.8843 412.3185
Cash & Cash Equivalents and Net AssetsTriparty Repo6.0053 26.0959
Cash & Cash Equivalents and Net AssetsNet Current Assets/(Liabilities)-0.8896 -3.8658
Total 5.1157 22.2301
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.